Sponsored Webinar: Precision Medicine for Sepsis: Targeted Therapy Based on Molecular Endotyping

Webinar Description: 

Sponsored by Spectral Medical Inc. 

Although overall mortality rates for sepsis are decreasing, some forms of sepsis—particularly severe sepsis that is sudden in onset—continue to claim many lives. Some of these aggressive forms of sepsis have been tied to molecular mechanisms that can offer new treatment targets. This webinar will focus on current methods used to identify sepsis subtypes and explore targeted therapies for such patients. 

This course was originally recorded on 9/30/2021. 

Target Audience

Nurses, physicians, pharmacists, emergency responders, healthcare management teams, and other healthcare staff may benefit.

Learning Objectives

At the end of the webinar, the attendee should be able to: 

  • Explain why sepsis is a heterogenous syndrome.
  • Define sepsis endotypes and explain why they are critical in achieving progress in sepsis therapy.
  • Discuss the role of damage and pathogen-associated molecular patterns in pathogenesis of sepsis and in developing treatments.

Sepsis Alliance gratefully acknowledges the support provided for this webinar by Spectral Medical Inc. 

Course summary
Course opens: 
06/15/2019
Course expires: 
12/31/2024

John A. Kellum, MD, MCCM

Chief Medical Officer, Spectral Medical Inc.

Dr. John Kellum is a distinguished Professor at the University of Pittsburgh, Department of Critical Care Medicine (currently on leave) and UPMC Endowed Chair in Critical Care Research. He has over 25 years experience as a practicing intensive care physician and has a Master of Critical Care Medicine from American Collage of Critical Care Medicine. Dr. Kellum has been an NIH-funded investigator for over 20 years. He is a highly-cited researcher and is an expert in sepsis, ranked by Web of Science Top 1% and by expertscape.com in the top 0.0029%.

No continuing education credits are offered for this sponsored webinar. 

Medical Disclaimer

The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

Please login or register to take this course.

Welcome to the webinar, Precision Medicine for Sepsis: Targeted Therapy Based on Molecular Endotyping.

Please proceed to download the slides, then view the webinar.

No continuing education credits are offered for this sponsored webinar.